Perrigo Co. Plc (PRGO)
10.68
+0.07
(+0.66%)
USD |
NYSE |
May 18, 16:00
10.68
0.00 (0.00%)
After-Hours: 20:00
Perrigo EPS Diluted (Quarterly) : -2.874 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 4.434 |
| Avadel Pharmaceuticals Plc | 0.0002 |
| Johnson & Johnson | 2.141 |
| Pfizer Inc. | 0.4688 |
| Ligand Pharmaceuticals, Inc. | -0.6712 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -389.90M |
| Revenue (Quarterly) | 969.10M |
| Total Expenses (Quarterly) | 1.359B |
| Enterprise Value | 4.926B |
| Gross Profit Margin (Quarterly) | 33.65% |
| Profit Margin (Quarterly) | -40.23% |
| Earnings Yield | -122.7% |
| Operating Earnings Yield | 19.88% |
| Normalized Earnings Yield | -38.95 |